European Urology

Article	Citations
Manfred Wirth – A life devoted to urology in a time of change	1056
Editorial Board	1009
Congress Calendar	570
Contents	467
Re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination The	456
Editorial Board	448
Re: Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes	434
Contents	434
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer	329
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma	314
Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?	304
Contents	266
Congress Calendar	238
Reply to Laurence Klotz’s Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of “Manels” in Major Urology	214
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors	210
Photodynamic diagnosis (PDD) directed biopsies vs white light bladder mapping in patients with positive cytology and negative preoperative workup: An international multicenter retrospective study. On	191
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma	168
Use cluster analysis to develop an accurate and practical diagnostic method for detrusor underactivity in female patient without bladder outlet obstruction	164
A comprehensive in vitro assessment of thulium fiber laser in soft tissues and stones	155
Minimally invasive adrenalectomy for the treatment of malignant adrenal metastasis: Results from two high volume centers	145
Transcriptomic analysis of the lncRNA-miRNA-mRNA axis network in aldosterone-producing adenoma	140
Robot-assisted radical prostatectomy for prostate cancer: 18-year oncological outcomes from a Belgian high-volume center	138
Surgical outcomes of robot-assisted radical prostatectomy with the novel HUGO™ robotic system: Initial 100 cases performed at a tertiary referral robotic center	130
Functional and endoscopic results up to two years after Aquablation for BPH-related LUTS: A single centre first clinical experience	125
Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer	121

Protein-based molecular subtypes associate with clinical-pathological characteristics in a multi-institutional cohort of upper tract urothelial carcinomas	118
What are the optimal laser settings for stone dusting using the popcorn technique	118
Cumulative thulium fiber laser energy and stone-free rates: Outcomes from the team of worldwide endourological researchers (TOWER) thulium fiber laser registry	116
Clinicopathological correlate of urine 8-hydroxydeoxyguanosine levels in patients with prostate biopsy	111
AI-based classification and segmentation method for bladder cancer from cystoscopic image: Preliminary study	108
Quantitative MRI parameters providing the novel value in discriminating muscle-invasive bladder cancer	106
Urolithiasis in patients with kidney transplantation: Multicenter KSER research series	104
Development and validation of a new personalized algorithmic model for PSA analysis : PROSTia	103
Igloo-technique for robotic radical prostatectomy — maximum nerve sparing for early recovery of continence and sexual function	103
Comparison of two different approaches in the management of infants with primaryobstructive megaureters and their long-term outcomes	100
Epidermal growth factor-like domain 7 inhibit immune response in metastatic castration resistant prostate cancer by de-activation of endothelial intercellular adhesion molecule-1	100
Utility of robotic platform for upper and mid ureteric reconstruction: Our experience at MPUH, Nadiad	97
More micrometastases, more recurrence? Assessing the role of quantitative rtPCR of PSA from lymph nodes post-prostatectomy in predicting biochemical recurrence - an experimental study	94
Assessing the potential of cystatin 4 as a blood biomarker for prostate cancer diagnosis and prognosis: A prospective single-center study	92
Prostate cancer prevention clinic for men with risk of familial prostate cancer (profam-risk)	89
The impact of adjuvant chemotherapy on overall survival in patients with node-positive Upper Tract Urothelial Carcinoma (UTUC): Improving precision in medicine with a risk-stratified approach	89
Management of renal cell carcinoma in transplant kidney: An individual patient data meta-analysis and evidence-based guide	89
The effect of duration between sessions on biofeedback treatment in children with dysfunctional voiding	87
Incontinence in boys and girls following succesful primary closure of bladder extrophy: Management with orthotopic ileal neobladder and costruction of anterior intrapelvic neourethra derived from detr	87
Radiomics-based prognostic model guided by artificial intelligence to predict lymph node invasion and biochemical recurrence in patients with high-grade prostate cancer	86
Is testosterone replacement therapy effective and safe even for eugonadal men with symptom of late onset hypogonadism?	86
Replacing ReTUR with Cystoscopy in High-Grade T1 NMIBC patients: Confirmatory results from the HuNIRe Trial	85
Retzius-sparing robot-assisted radical prostatectomy for large prostate volumes: Surgical and functional outcomes	84
Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study	83
Comparing PSA screening patterns and their role as predictor of prostate cancer incidence and mortality: A system wide analysis of a contemporary North American cohort	80
Single-port vs. multi-port robot-assisted partial nephrectomy: A single center propensity-score matched analysis	80
Impact of radical prostatectomy on pelvic floor muscles: An electromyography and perineometric assessment	80
The next generation trial: Assessing 18F-PSMA-1007 positron emission tomography and magnetic resonance imaging in the primary staging of prostate cancer patients	79
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer	77
Epidemiological outcomes in immunocompromised vs. immunocompetent prostate cancer patients: A systematic review, meta-analysis and meta-regression	75
The surgical learning curve for cancer control after robot-assisted radical prostatectomy	73
Delayed absent ejaculation in men presenting to the fertility clinic – retrospective cohort study	73
Sutureless robot assisted partial nephrectomy: Feasibility and surgical technique (UroCCR n°158)	72
Outcomes according to histological variants of urothelial carcinoma after neoadjuvant chemotherapy in the GETUG-AFU V05 VESPER trial	72
Strengths and weaknesses of using Optum Clinformatics Data Mart to study in-vitro fertilization	72
A randomized controlled trial comparing 1470nm diode laser vs. plasmakinetic enucleation of the prostate for treating benign prostatic hyperplasia	72
Efficacy and safety of low-dose tadalafil compared to tolterodine and placebo in females with overactive bladder symptoms. A prospective double blind controlled study	70
Propensity-score matched survival analysis of octogenarians with muscle-invasive bladder cancer: Chemoradiation compared to radical cystectomy	69
MRI/US fusion targeted prostate biopsies koelis®: Impact of operator experience on clinicaly significant prostate cancer detection	69
Short-term morbidity and long-term functional outcomes of the T-plasty for salvage reconstruction of recalcitrant bladder neck stenosis	68
Incidental prostate cancer in patients treated for benign prostatic hyperplasia: Analysis from a contemporary national dataset	68
Qualitative assessment of patient-reported outcomes in urinary and sexual function in patient after perineal urethrostomy	68
Prognostic impact of clear cell renal cell carcinoma molecular subtypes determined on formalin-fixed paraffin-embedded tissue samples on outcome after complete surgical metastasectomy	66
Efficacy and safety of darolutamide in combination with androgen-deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial	65
Non-infectious adverse events of transperineal prostate biopsies performed under local anesthesia in an outpatient setting – results from the NORAPP study – a randomized clinical trial	64
De-escalation of monitoring for prostate cancer active surveillance: Results of the GAP3 consortium	64
Prostatectomy vs. radiotherapy for regional node positive prostate cancer	64
Fosfomycin for antibiotic prophylaxis in men undergoing a transrectal prostate biopsy: A systematic review and meta-analysis	64
Improved survival in contemporary actively treated community-based metastatic clear-cell renal cell carcinoma patients	63
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: A meta-analysis	62

Radiomics model to predict teratoma in metastatic non-seminomatous testicular germ cell tumors	61
Persistently elevated urinary inflammatory biomarkers may predict recurrence of recurrent urinary tract infection in women	60
Surgical and oncologic outcomes of surgery in early metastatic seminoma: Multi-institutional retrospective study	60
Re-treatment for Lower Urinary Tract Symptoms (LUTS) after water vapor thermal therapy	60
Rezūm water vapour therapy (Rezūm): Is it safe to continue antiplatelet or anticoagulation medication?	60
Prognostic value of circulating tumor cells and cell-free DNA in upper tract urothelial carcinoma	59
Prenatal exposure to SSRI antidepressants and time of neonatal first void - A case control study	58
Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) scoring system: A two-reader, two-centre study	58
The international bladder cancer group intermediate-risk non-muscle invasive bladder cancer (IBCG IR-NMIBC) scoring system predicts the need for intervention for patients on active surveillance	57
Guidewire-marking before robotic salvage lymph node dissection for in-field lymph node recurrences after radical prostatectomy: Initial experiences	57
100 years of history-making urology – the Portuguese urology association	57
Impact of systemic therapy in clinical T1 small-cell neuroendocrine carcinoma of the bladder	57
Orificial surgery at the turn of the 20th century: Not exactly a precursor of current NOTES, but another embarrassing chapter in the history of modern surgery	57
Immunoprophyaxis with MV-140 is effective in the prevention of urinary tract infections – results of a prospective study	55
Which men with cN1 prostate cancer at PSMA PET/CT represent the ideal candidate for radical prostatectomy? Development of a novel risk stratification tool for individualized approaches based on a larg	55
Reclassification of small renal masses according to the EAU Guidelines newly-proposed TNM classification for suspected renal cell carcinoma: Implications for decision-making	54
Development of an individual postoperative prediction model for kidney cancer recurrence using machine learning (UroCCR study 120)	54
Prospective randomized comparison of SP TFL and Ho:YAG in RIRS for kidney stones: a single-center study	54
First-in-human experience with the LithoVueTM elite single use ureteroscope: Can intrarenal pressure be manipulated?	54
First clinical experience with a novel approach of robot-assisted completely retroperitoneal nephroureterectomy with bladder cuff	53
Robot-assisted video-endoscopic radical inguinal lymphadenectomy for penile cancer: surgical anatomy and technique	53
Spontaneous passage rate of ureteral stones and predictive factors after pre-stenting	53
Efficacy of recombinant Bacillus Calmette-Guérin–dltA in three-dimensional bioprinted bladder cancer-on-a-chip with microfluidic system	52
Comparison of clinical outcomes after phalloplasty with versus without urethral lengthening in transgender men	52
Head to head comparison between RENAL and PADUA nephrometry scores in predicting TRIFECTA achievement in off-clamp Robot-assisted partial nephrectomy	52
Salvage focal ablation versus radical prostatectomy for localized radiorecurrent prostate cancer: A propensity-score matched comparison	52
Minimally invasive cytoreductive nephrectomy for metastatic renal cell carcinoma in the immunotherapy era: Results from the REMARC-IO database	52
A prospective paired comparison trial on mirabegron and anticholinergics in patients with low bladder compliance	51
Erogenous and aversive sensation throughout the vulva, vagina, and breasts in cis-gender women: Anatomic heat-map to assess effect of treatment on erogenous sensation	51
Efficacy of sacral nerve modulation in the treatment of neurogenic overactive bladder in patients with multiple sclerosis	49
Do patients prefer telecommunication to traditional face-to face clinic review: A benefit of covid-19?	49
Gender disparities in editorial board of academic urology journals	49
Mechanism of cystine stone growth revealed by ultrastructural observation using scanning electron microscopy	47
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups	47
Efficacy of tamsulosin versus mirabegron for ureteric stent related symptoms: Prospective randomized questionnaire based comparison	46
The feasibility and advantages of an at-home intravesical therapy service for benign conditions	46
The development of a hollow three-dimensional kidney spheroid model for the study of calcium-containing crystal formation	45
Bladder EpiCheck methylation test predicts short- and long-term HG events in bladder cancer patients treated with bacillus Calmette-Guérin	45
Risk factors for postoperative infections after urological surgery: Preliminary results from the national and multicenter TOCUS study	45
The complications of synthetic mid-urethral slings: The discrepancy between demographic data and clinical trials- a systematic review with meta-analysis	45
What is new at the deepest point of human civilization for andrologic point of view?	45
LEST: Anatomical ablative ejaculation sparing surgery for BPH	44
3D laparoscopic versus robot assisted laparoscopic prostatectomy, a randomized prospective study. Preliminary 1-year functional results	44
Outcomes of urethroplasty (UP), 10 years after surgery	43
Validation of a simplified prognostic model for survival in patients with extrinsic malignant ureteral obstruction treated with tandem ureteral stents	43
Incremental value of machine learning-based radiomics for preoperative discrimination between malignant and benign small renal masses	43
Multi-centre study comparing outcomes of RIRS using traditional suction ureteral access sheath (SUAS) and flexible-navigable suction UAS (FANS)	43
SWL is more cost-effective than fURS for the management of kidney stones: Comparative study in a tertiary care centre	42
Comparing urine and stone microbiome in urolithiasis patients	42
Real-world cost for first-line treatment for prostate cancer: A comparative cost analysis in the public sector	42
The use of abdominal drain after robot-assisted surgery in urology: Impact on postoperative pain	41
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade	41
Hsa_circ_0005221 promotes prostate cancer progression through miR-339-5p/ STAT5a	41
Evaluation of the effect of umbilical cord derived urethral slings in bilateral pudendal nerves injury-induced urinary incontinence in female rats	40
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial	40
Intravesical injection with abobotulinumtoxin-A in patients with bladder pain syndrome/ interstitial cystitis	40
Re: Bhavan P. Rai, José Luis Dominguez Escrig, Luís Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria.	40
Prostatic artery embolization compared to trans-urethral resection of the prostate and prostatic urethral lift: A real-world population-based study	40
Honing Stratification and Treatment for High-risk Prostate Cancer	39
Re: Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al. Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naïve Men: PI-RADS Steering Committee, Version 1.0.	39
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma	39
Re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature	39
More Than Words: Defining Adjuvant, Consolidative, and Salvage Treatment after Radical Prostatectomy	38
Re: Association of Black Race with Prostate Cancer–specific and Other-cause Mortality	38
Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase	38
The Platinum Hall of Fame	38
Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.11.003	38
Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome:	38
The Platinum Hall of Fame	38
Re: The Prognostic Value of p53 and Ki-67 Expression Status in Penile Cancer: A Systematic Review and Meta-analysis	37
Editorial Board	37
Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor	36
Acknowledgement to Reviewers	36
Re: Duration of Androgen Deprivation Therapy with Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-course Versus Short-course Androgen Deprivation Therapy in the RADICALS-HD Random	35
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided	35
18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging	34
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study	34
A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma	34
Growth of the Twitter Presence of Academic Urology Training Programs and Its Catalysis by the COVID-19 Pandemic	34
Tumors of the Urinary System and Male Genital Organs: 2022 World Health Organization Classification and Multidisciplinarity	34

Re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial.	34
Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association	33
Re: Marcio Covas Moschovas, Shady Saikali, Marco Sandri, et al. Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robot	33
Mapping Contemporary Biopsy Zones to Traditional Prostatic Anatomy: The Key to Understanding Relationships Between Prostate Cancer Topography, Magnetic Resonance Imaging Conspicuity, and Clinical Risk	33
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Tria	33
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy	33
Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials	32
Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?	32
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial	32
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger’s Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinica	31
Re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential	31
Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Cu	31
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution	30
Prostate Cancer Active Surveillance Without Biopsy? Not Quite Yet, but Watch This Space	30
Prostate-Specific Antigen Screening in Transgender Patients	30
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update	29
Paul Rosenstein 1875-1964, a Jewish urologist in troubled times	29
Re: Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis	29
Contents	29
Clinical outcomes of intracytoplasmic sperm injection using ejaculated or testicular sperm in patients with AZFc deletions	28
Role of ureteroscopy and stone treatment in management of recurrent UTIs: Prospective outcomes over a 10-year period	28
Shorter abstinence period on semen parameters among ejaculated sperm samples: Better or worse? A systematic review and meta-analysis	28
Safety and tolerability of single-j vs. double-j stents after ureterorenoscopy – a randomized trial	28
Prognostic impact of variant histology in bladder cancer: Would early and aggressive treatment shift the paradigm?	28
Can we predict for missed clinically significant prostate cancers on MRI-Targeted biopsy alone?	28
Preoperative or intraoperative renal biopsy increases the accuracy in predicting lymph node invasion in patients with renal cell carcinoma	28
Restoration of bladder function by inhibition of the Ninjurin-1 pathway in rat model of spinal cord injury	28
Is robot-assisted simple prostatectomy associated with worse outcomes in obese patients?	27
Bladder NIRS: A non-invasive method functional to distinguish between detrusor underactivity (DU) and Bladder Outlet Obstruction (BOO) in men with LUTS	27
Expanding the use of targeted therapy for Urothelial Bladder Cancer (UBC): Non-FGFR3 Receptor Tyrosine Kinase (RTK) Gene Rearrangements (ReAr) and Fusions (Fus)	26
Epigenetic dysregulation of tumor suppressor genes in cp⁄cpps: Studies on liquid biopsies for biomarker development	26
Oncologic outcomes of patients with incidental prostate cancer: Can we rely on multiparametric mri to exclude aggressive prostate cancer?	26
Baseline characteristics and outcomes of 10.485 prostate cancer patients on delayed palliative management: A report from PIONEER, a big data for better outcome programme	26
Assessment of the oncological safety of NICE guidelines on low risk bladder cancer surveillance	26
Nontransecting anastomotic urethroplasty via ventral approach without full mobilization of the corpus spongiosum dorsal semicircumference	26
Increased renal uptake and urine excretion of oxidized LDL is possibly associated with formation of large calcium oxalate nephrolithiasis	26
Pharmacological modulation of intrarenal pressure using a novel isoprenaline eluting guidewire (IsoWire)	25
Oncological outcomes in patients with recurrent prostate cancer staged with PSMA PET/CT: Results from 3 European tertiary centers	25
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication	25
Feasibility of first postoperative day foley catheter removal after robotic assisted radical prostatectomy	25
Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid	24
Real-world outcomes versus clinical trial results for first-line systemic treatment in patients with unresectable stage-IV urothelial carcinoma of the bladder	24
The timing of (salvage) radiotherapy influences the outcomes of bladder neck incision for bladder neck stenosis after robot-assisted radical prostatectomy	24
New biomarker for erectile dysfunction: Soluble Tumor necrosis factor-like Weak inducer of apoptosis (sTWEAK)	24
Perinephric toxic fat: Impact on surgical complexity, perioperative outcome and surgical approach in partial nephrectomy	24
Is the Urolift a fertility sparing technique in patients suffered from BPH?	24
Platelet RNAs as potential biomarkers in prostate cancer detection: Highlighting differential expression of hsa-miR-627, hsa-miR-22, and hsa-miR-190	24
Protective effect of LCZ696 on kidney function after partial nephrectomy	24
Study of abdominal testicular vessels distribution in human fetuses: anatomical basis for laparoscopic fowler-stephens surgery	24
Patient characteristics and dynamic variables predictive of meaningful quality of life and sexual function improvement after Prostatic Urethral Lift (PUL)	24
Anatomical transcriptome atlas of the male mouse reproductive system during aging	24
Comparison of pediatric and adult patients wıth ureteropelvic junction obstruction in terms of nerve number, connective tissue and ganglion cell existence	24
Stockholm3 validation in a multi-Ethnic cohort for ProsTAte cancer (SEPTA) detection: A multicentered, prospective trial	23
A drug-coated ballon treatment for urethral stricture: A multicenter Italian real-life study	23
What if they continued the pregnancy? Using prenatal ultrasound findings to predict postnatal outcomes for fetuses with Lower Urinary Tract Obstruction (LUTO) to improve counseling and aid in decision	23
Assessing the regional variability of a pre-biopsy mpMRI and targeted prostate cancer diagnostic pathway	23
‘Aphrodite’ and ‘Priapus’: The mother-son duo from Greek mythology and their link to urology	23
Spatial mapping reveals the transcriptome and anatomic heterogeneity of human and rat corpus cavernosum	23
Sexuality in men after kidney transplantation	23
Retrocaval ureter: Robot assisted ureterolithotomy and ureteral transposition	22
Protective effects of regulatory T cells in renal ischemia/reperfusion injury in mice	22
Translational Research in BPS/IC: How can silodosin improve pain and frequency both in mice and female patients?	22
A systematic review and meta-synthesis of qualitative evidence on overactive bladder for the development of a Core Outcome Set	22
CaOx stone patients derived exosome miR-146a-5p regulates CaOx stone progression and immune microenvironment	22
Management patterns of male urethral stricture disease among urologists: What do the guidelines say? What do urologists do?	22
How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: A novel risk stratification tool	22
Novel strategy for combining penile erection restoration and factual girth enhancement based on de novo penile fibrovascular assembly	22
Vector prostate biopsy: A novel electro-magnetic biopsy technique for mpMRI/US fusion transperineal prostate biopsies under local anaesthesia	21
YV plasty for vesico-urethral anastomosis stenosis by combined robotic and perineal approach and concomitant artificial urinary sphincter implantation	21
A novel multi-imaging based focal therapy program for prostate cancer with high intensity focused ultrasound: Early oncological outcomes of a single-center experience	21
Outcomes of penile cancer stratified by nodal staging: Importance of pelvic nodal involvement	20
Development of a novel diagnostic model for urological cancers using comprehensive N-glycan signatures of serum immunoglobulins with a machine learning approach	20
Preoperative upper tract invasive diagnostic modalities are associated with intravesical recurrence following surgery for upper tract urothelial carcinoma: A population-based study	20
Concordance of renal sinus or calyces invasion between preoperative imaging and final pathology after surgery for kidney cancer	20
Predictive factors for failure of surgical treatment of vesicovaginal fistulas	20
ACTG2-autosomal dominant visceral myopathy: Identification of novel variants using data from Genomics England 100,000 Genomes Project	20
Inflammatory chemokines upregulated in the tumor microenvironment of prostate cancer patients experiencing relapse after radical prostatectomy	20
Preclinical assessment of integrin receptors as therapeutic targets in advanced treatment-resistant prostate cancer	20
Clinical significance of SCHLAP1:UBE2E3 gene fusion compared to TMPRSS2:ERG gene fusion in localized prostate cancer: Insights from a Korean cohort	20
Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel-Lindau renal cell carcinoma	20
Challenging the dogma: Should unilateral pelvic lymph node dissection be envisioned in the multiparametric prostate MRI era?	20
Probability of detecting significant and aggressive prostate cancer by MRI-identified lesions in a series of biopsy naïve-men	20
Safety and efficacy of personalized LND vs. ePLND during radical prostatectomy. Personalympca: A randomized phase II study	20
The implementation of systematic biopsies in the endoscopic management of upper tract urothelial cancer	20
Usefulness of stone culture in endoscopic combined intra-renal surgery	20
Endoscopic treatment of parapelvic renal cysts	20
Benefit of whole-pelvis radiation for patients with muscle-invasive bladder cancer: An inverse probability treatment weighted analysis	19
A symptomatic spontaneous stone passage is frequent in recurrent kidney stone formers: Results of the prospective, randomized NOSTONE trial	19
Predictive value of preoperative high sensitive C-reactive protein/ albumin ratio in systemic inflammatory response syndrome after semi-rigid ureteroscopy	19
Do French urologists suffer from imposter syndrome? A survey	19
Feasibility of ethical surgical training using simulation and 3D printed synthetic organs	19
The role of varicocele correction in men with a clinical varicocele and non-obstructive azoospermia	19
Use of allium ureteral stents for managing iatrogenic ureteric injuries	19
Robot-assisted sacrocolpopexy versus trans-vaginal prolapse repair: Impact on lower bowel tract function	19
Health-related quality of life following cytoreductive radical prostatectomy in patients with de-novo oligometastatic prostate cancer	19